Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 51 citing articles:

Dual VEGFR-2 and EGFR T790M inhibitors of phenyldiazenes: anticancer evaluations, ADMET, docking, design and synthesis
Marwa Alsulaimany, Ahmed K. B. Aljohani, Nour E. A. Abd El‐Sattar, et al.
Future Medicinal Chemistry (2025) Vol. 17, Iss. 3, pp. 287-300
Closed Access | Times Cited: 1
Designing strategies, structural activity relationship and biological activity of recently developed nitrogen containing heterocyclic compounds as epidermal growth factor receptor tyrosinase inhibitors
Rohit Pal, Ghanshyam Teli, Gurubasavaraja Swamy Purawarga Matada, et al.
Journal of Molecular Structure (2023) Vol. 1291, pp. 136021-136021
Closed Access | Times Cited: 31
Benzimidazole-Triazole Hybrids as Antimicrobial and Antiviral Agents: A Systematic Review
Maria Marinescu
Antibiotics (2023) Vol. 12, Iss. 7, pp. 1220-1220
Open Access | Times Cited: 29
A Review on the Green Synthesis of Benzimidazole Derivatives and Their Pharmacological Activities
Mónica Nardi, Natividad Herrera Cano, Svilen P. Simeonov, et al.
Catalysts (2023) Vol. 13, Iss. 2, pp. 392-392
Open Access | Times Cited: 27
Antitumor Activity of s-Triazine Derivatives: A Systematic Review
Qiuzi Dai, Qinsheng Sun, Xiaorong Ouyang, et al.
Molecules (2023) Vol. 28, Iss. 11, pp. 4278-4278
Open Access | Times Cited: 24
In silico and in vitro prediction of new synthesized N-heterocyclic compounds as anti-SARS-CoV-2
Heba E. Hashem, Sajjad Ahmad, Ajoy Kumer, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 12
Anticancer activity of new triazolopyrimidine linked coumarin and quinolone hybrids: Synthesis, molecular modeling, TrkA, PI3K/AKT and EGFR inhibition
Rasha Z. Batran, Eman Y. Ahmed, Eman S. Nossier, et al.
Journal of Molecular Structure (2024) Vol. 1305, pp. 137790-137790
Closed Access | Times Cited: 10
Recent biological applications of heterocyclic hybrids containing s-triazine scaffold
Muhammad Imran Ali, Muhammad Moazzam Naseer
RSC Advances (2023) Vol. 13, Iss. 43, pp. 30462-30490
Open Access | Times Cited: 19
Novel pyridine-thiazolidinone-triazole hybrid glycosides targeting EGFR and CDK-2: Design, synthesis, anticancer evaluation, and molecular docking simulation
Asmaa F. Kassem, Mohamed A. Omar, Eman S. Nossier, et al.
Journal of Molecular Structure (2023) Vol. 1294, pp. 136358-136358
Closed Access | Times Cited: 17
Nitrogen‐Containing Heterocyclic Scaffolds as EGFR Inhibitors: Design Approaches, Molecular Docking, and Structure‐Activity Relationships
Rohit Pal, Ghanshyam Teli, Gurubasavaraja Swamy Purawarga Matada, et al.
ChemistrySelect (2023) Vol. 8, Iss. 26
Closed Access | Times Cited: 15
Five and six membered heterocyclic rings endowed with azobenzene as dual EGFRT790M and VEGFR-2 inhibitors: design, synthesis, in silico ADMET profile, molecular docking, dynamic simulation and anticancer evaluations
Kurls E. Anwer, Sanadelaslam S. A. El‐Hddad, Nour E. A. Abd El‐Sattar, et al.
RSC Advances (2023) Vol. 13, Iss. 50, pp. 35321-35338
Open Access | Times Cited: 15
New thiazole derivatives linked to pyridine, fused pyridine, pyrimidine and thiazolopyrimidine scaffolds with potential dual anticancer and antimicrobial activities: Design, synthesis and docking simulation
Zahra M. Al-Amshany, Eman S. Nossier
Journal of Molecular Structure (2024) Vol. 1316, pp. 138973-138973
Closed Access | Times Cited: 6
New 1,2,3-Triazole-Coumarin-Glycoside Hybrids and Their 1,2,4-Triazolyl Thioglycoside Analogs Targeting Mitochondria Apoptotic Pathway: Synthesis, Anticancer Activity and Docking Simulation
Wael A. El‐Sayed, Fahad M. Alminderej, Marwa M. Mounier, et al.
Molecules (2022) Vol. 27, Iss. 17, pp. 5688-5688
Open Access | Times Cited: 26
Recent Advances in the Anticancer Applications of Benzimidazole Derivatives
Mohammad Mavvaji, Senem Akkoç
ChemistrySelect (2023) Vol. 8, Iss. 35
Closed Access | Times Cited: 12
Design, Synthesis, and Biological Evaluation of Newly Synthesized Cinnamide-Fluorinated Containing Compounds as Bioactive Anticancer Agents
Dalal Nasser Binjawhar, Fawziah A. Al‐Salmi, Maha Al‐Ghamdi, et al.
ACS Omega (2024) Vol. 9, Iss. 16, pp. 18505-18515
Open Access | Times Cited: 3
Novel imidazolone derivatives as potential dual inhibitors of checkpoint kinases 1 and 2: Design, synthesis, cytotoxicity evaluation, and mechanistic insights
Yasmin S. Sheta, Marwa T. Sarg, Fatma G. Abdulrahman, et al.
Bioorganic Chemistry (2024) Vol. 149, pp. 107471-107471
Closed Access | Times Cited: 3
Chemical synthesis and molecular docking study of new thiazole, thiophene, and thieno[2,3-d]pyrimidine derivatives as potential antiproliferative and antimicrobial agents
Ismail M. M. Othman, Zahra M. Al-Amshany, Nada Y. Tashkandi, et al.
Journal of Molecular Structure (2022) Vol. 1270, pp. 133926-133926
Closed Access | Times Cited: 17
Modified pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as EGFRWT and EGFRT790M inhibitors: Design, synthesis, and anti-cancer evaluation
Eman S. Nossier, Rania A. Alasfoury, Mohamed Hagras, et al.
Journal of Molecular Structure (2022) Vol. 1270, pp. 133971-133971
Closed Access | Times Cited: 16
Designing Potent Anti-Cancer Agents: Synthesis and Molecular Docking Studies of Thieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimidine Derivatives
Eman S. M. Elsenbawy, Zafer Saad Alshehri, Nouf A. Babteen, et al.
Molecules (2024) Vol. 29, Iss. 5, pp. 1067-1067
Open Access | Times Cited: 2
Synthesis, computational studies and evaluation of benzisoxazole tethered 1,2,4-triazoles as anticancer and antimicrobial agents
Deepika Dwarakanath, K. Ananda, Basappa Basappa, et al.
Journal of Molecular Structure (2024) Vol. 1308, pp. 138070-138070
Open Access | Times Cited: 2
Synthesis of Novel Triazine-Based Chalcones and 8,9-dihydro-7H-pyrimido[4,5-b][1,4]diazepines as Potential Leads in the Search of Anticancer, Antibacterial and Antifungal Agents
Leydi M. Moreno, Jairo Quiroga, Rodrigo Abonı́a, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3623-3623
Open Access | Times Cited: 2
Trinuclear ruthenium(II) polypyridyl complexes: Evaluation as photosensitizers for enhanced cervical cancer treatment
Athi Welsh, Refilwe Matshitse, Saif F. Khan, et al.
Journal of Inorganic Biochemistry (2024) Vol. 256, pp. 112545-112545
Open Access | Times Cited: 2
Synthesis, Crystal Structure, Hirshfeld, DFT, Molecular Docking, Dynamics Studies, and Anti-cancer Activity of 1-Substituted-2-(4-(diethylamino)-2-hydroxyphenyl)- 1H-benzo[d]imidazole-5-ethyl carboxylates
D. Ganavi, Vasantha Kumar, P. Akhileshwari, et al.
Journal of Molecular Structure (2024) Vol. 1314, pp. 138657-138657
Closed Access | Times Cited: 2
Pyridine-Based Glycosides Bearing 1,2,4-Triazole and Their 1,3,4-oxadiazole analogues as Potential EGFR and CDK-2 Inhibitors: Design, Synthesis, Antiproliferative Activity and In Silico Studies
Asmaa F. Kassem, Ahmed Younis, Eman S. Nossier, et al.
Journal of Molecular Structure (2024) Vol. 1313, pp. 138741-138741
Closed Access | Times Cited: 2
New sulfonamide-based glycosides incorporated 1,2,3-triazole as cytotoxic agents through VEGFR-2 and carbonic anhydrase inhibitory activity
Hebat‐Allah S. Abbas, Eman S. Nossier, May A. El‐Manawaty, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top